Search by Drug Name or NDC
NDC 00280-4100-63 Alka-Seltzer Gold 1000; 344; 1050 mg/1; mg/1; mg/1 Details
Alka-Seltzer Gold 1000; 344; 1050 mg/1; mg/1; mg/1
Alka-Seltzer Gold is a ORAL TABLET, EFFERVESCENT in the HUMAN OTC DRUG category. It is labeled and distributed by Bayer HealthCare LLC.. The primary component is CITRIC ACID MONOHYDRATE; POTASSIUM BICARBONATE; SODIUM BICARBONATE.
Product Information
| NDC | 00280-4100 |
|---|---|
| Product ID | 0280-4100_0bb5329c-888f-9e66-e063-6394a90a3b9e |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Alka-Seltzer Gold |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Alka-Seltzer Gold |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, EFFERVESCENT |
| Route | ORAL |
| Active Ingredient Strength | 1000; 344; 1050 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | CITRIC ACID MONOHYDRATE; POTASSIUM BICARBONATE; SODIUM BICARBONATE |
| Labeler Name | Bayer HealthCare LLC. |
| Pharmaceutical Class | Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M001 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00280-4100-63 (00280410063)
| NDC Package Code | 0280-4100-63 |
|---|---|
| Billing NDC | 00280410063 |
| Package | 18 POUCH in 1 CARTON (0280-4100-63) / 2 TABLET, EFFERVESCENT in 1 POUCH |
| Marketing Start Date | 2014-11-19 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |